Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Hoff

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
Case Reports in Oncology|December 19, 2013
Gastric and endobronchial metastases in a case of lobular breast cancerG S Fernandes, T S Corrêa, E P B Carvalho, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
Colorectal cancer: chemotherapy treatment overviewM E Royce, D Medgyesy, T H Zukowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2012
Oxaliplatin-related thrombocytopeniaD L Jardim, C A Rodrigues, Y A S Novis, et al.
Cancer|March 10, 2001
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumorsP Kozuch, P M Hoff, K Hess, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
Oncology|August 7, 1999
Fluoropyrimidines: a critical evaluationR A Brito, D Medgyesy, T H Zukowski, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
British Journal of Cancer|March 2, 2013
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapyJ M Jürgensmeier, H-J Schmoll, J D Robertson, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
Case Reports in Oncology|December 19, 2013
Gastric and endobronchial metastases in a case of lobular breast cancerG S Fernandes, T S Corrêa, E P B Carvalho, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
Colorectal cancer: chemotherapy treatment overviewM E Royce, D Medgyesy, T H Zukowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2012
Oxaliplatin-related thrombocytopeniaD L Jardim, C A Rodrigues, Y A S Novis, et al.
Cancer|March 10, 2001
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumorsP Kozuch, P M Hoff, K Hess, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
Oncology|August 7, 1999
Fluoropyrimidines: a critical evaluationR A Brito, D Medgyesy, T H Zukowski, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
British Journal of Cancer|March 2, 2013
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapyJ M Jürgensmeier, H-J Schmoll, J D Robertson, et al.
Pageof 5